Skip to main content
Erschienen in: PharmacoEconomics 5/2005

01.05.2005 | Review Article

Valuing patient and caregiver time

A review of the literature

verfasst von: Dr Jennifer E. Tranmer, Denise N. Guerriere, Wendy J. Ungar, Peter C. Coyte

Erschienen in: PharmacoEconomics | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

As healthcare expenditures continue to rise, financial pressures have resulted in a desire for countries to shift resources away from traditional areas of spending. The consequent devolution and reform have resulted in increased care being provided and received within homes and communities, and in an increased reliance on unpaid caregivers. Recent empirical work indicates that costs incurred by care recipients and unpaid caregivers, including time and productivity costs, often account for significant proportions of total healthcare expenditures. However, many economic evaluations do not include these costs. Moreover, when indirect costs are assessed, the methods of valuation are inconsistent and frequently controversial.
This paper provides an overview and critique of existing valuation methods. Current methods such as the human capital method, friction cost method and the Washington Panel approach are presented and critiqued according to criteria such as potential for inaccuracy, ease of application, and ethical and distributional concerns. The review illustrates the depth to which the methods have been theoretically examined, and highlights a paucity of research on costs that accrue to unpaid caregivers and a lack of research on time lost from unpaid labour and leisure. To ensure accurate and concise reporting of all time costs, it is concluded that a broad conceptual approach for time costing should be developed that draws on and then expands upon theoretical work to date.
Literatur
1.
Zurück zum Zitat Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1995 Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1995
2.
Zurück zum Zitat Andersson A, Levin L, Emtinger B. The economic burden of informal care. Int J Technol Assess Health Care 2002; 18 (1): 46–54PubMed Andersson A, Levin L, Emtinger B. The economic burden of informal care. Int J Technol Assess Health Care 2002; 18 (1): 46–54PubMed
3.
Zurück zum Zitat Coyte PC, Asche CV, Croxford R, et al. The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res 1998; 11 (5): 315–25PubMedCrossRef Coyte PC, Asche CV, Croxford R, et al. The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res 1998; 11 (5): 315–25PubMedCrossRef
4.
Zurück zum Zitat Koopmanschap MA, Rutten FF. The impact of indirect costs on outcomes of health care programs. Health Econ 1994; 3 (6: 385–93PubMedCrossRef Koopmanschap MA, Rutten FF. The impact of indirect costs on outcomes of health care programs. Health Econ 1994; 3 (6: 385–93PubMedCrossRef
5.
Zurück zum Zitat Rothermich EA, Pathak DS. Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. Clin Ther 1999; 21 (1): 255–67PubMedCrossRef Rothermich EA, Pathak DS. Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. Clin Ther 1999; 21 (1): 255–67PubMedCrossRef
6.
Zurück zum Zitat van den Berg B, Brouwer WBF, Koopmanschap MA. Economic valuation of informal care: an overview of methods and applications. Ear J Health Econ 2004; 5 (1): 36–45CrossRef van den Berg B, Brouwer WBF, Koopmanschap MA. Economic valuation of informal care: an overview of methods and applications. Ear J Health Econ 2004; 5 (1): 36–45CrossRef
7.
Zurück zum Zitat Olsen JA, Richardson J. Production gains from health care: what should be included in cost-effectiveness analyses? Soc Sci Med 1999; 49: 17–26PubMedCrossRef Olsen JA, Richardson J. Production gains from health care: what should be included in cost-effectiveness analyses? Soc Sci Med 1999; 49: 17–26PubMedCrossRef
8.
Zurück zum Zitat Brouwer WBF, Koopmanschap MA, Rutten FFH. Patient and informal caregiver time in cost-effectiveness analysis: a response to the recommendations of the Washington Panel. Int J Technol Assess Health Care 1998; 14 (3): 505–13PubMedCrossRef Brouwer WBF, Koopmanschap MA, Rutten FFH. Patient and informal caregiver time in cost-effectiveness analysis: a response to the recommendations of the Washington Panel. Int J Technol Assess Health Care 1998; 14 (3): 505–13PubMedCrossRef
9.
Zurück zum Zitat Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ 1997; 6 (5): 511–4CrossRef Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ 1997; 6 (5): 511–4CrossRef
10.
Zurück zum Zitat Glied S. Estimating the indirect cost of illness: an assessment of the foregone earnings approach. Am J Public Health 1996; 86 (12): 1723–8PubMedCrossRef Glied S. Estimating the indirect cost of illness: an assessment of the foregone earnings approach. Am J Public Health 1996; 86 (12): 1723–8PubMedCrossRef
11.
Zurück zum Zitat Goeree R, O’Brien BJ, Blackhouse G, et al. The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Can J Psychiatry 1999; 44 (5): 455–63PubMed Goeree R, O’Brien BJ, Blackhouse G, et al. The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Can J Psychiatry 1999; 44 (5): 455–63PubMed
12.
Zurück zum Zitat Hutubessy RC, Van Tulder MW, Vondeling H et al. Indirect costs of back pain in The Netherlands: a comparison of human capital method with the friction cost method. Pain 1999; 80 (12): 201–7PubMedCrossRef Hutubessy RC, Van Tulder MW, Vondeling H et al. Indirect costs of back pain in The Netherlands: a comparison of human capital method with the friction cost method. Pain 1999; 80 (12): 201–7PubMedCrossRef
13.
Zurück zum Zitat Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation literature: a review. Int J Technol Assess Health Care 1998; 14 (4): 799–808CrossRef Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation literature: a review. Int J Technol Assess Health Care 1998; 14 (4): 799–808CrossRef
14.
Zurück zum Zitat Koopmanschap MA, Rutten FF. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4 (6): 446–54CrossRef Koopmanschap MA, Rutten FF. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4 (6): 446–54CrossRef
15.
Zurück zum Zitat Koopmanschap MA, Rutten FFH. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996; 10: 460–6PubMedCrossRef Koopmanschap MA, Rutten FFH. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996; 10: 460–6PubMedCrossRef
16.
Zurück zum Zitat Koopmanschap MA, van Ineveld BM. Towards a new approach for estimation indirect costs of disease. Soc Sci Med 1992; 34: 1005–10PubMedCrossRef Koopmanschap MA, van Ineveld BM. Towards a new approach for estimation indirect costs of disease. Soc Sci Med 1992; 34: 1005–10PubMedCrossRef
17.
Zurück zum Zitat Liljas D. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998; 13: 1–7PubMedCrossRef Liljas D. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998; 13: 1–7PubMedCrossRef
18.
Zurück zum Zitat Lofland III, Locklear JC, Frick KD. Different approaches to valuing the lost productivity of patients with migraine. Pharmacoeconomics 2001; 19 (9): 917–25PubMedCrossRef Lofland III, Locklear JC, Frick KD. Different approaches to valuing the lost productivity of patients with migraine. Pharmacoeconomics 2001; 19 (9): 917–25PubMedCrossRef
19.
Zurück zum Zitat Manning WG. Panel on cost-effectiveness in health and medicine recommendations: identifying costs. J Clin Psychiatry 1999; 60 Suppl. 3: 54–8PubMed Manning WG. Panel on cost-effectiveness in health and medicine recommendations: identifying costs. J Clin Psychiatry 1999; 60 Suppl. 3: 54–8PubMed
20.
Zurück zum Zitat Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253–8PubMedCrossRef Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253–8PubMedCrossRef
21.
Zurück zum Zitat Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982; 60: 429–62PubMedCrossRef Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982; 60: 429–62PubMedCrossRef
22.
Zurück zum Zitat Marcotte DE, Wilcox-Gok V. Estimating the employment and earnings costs of mental illness: recent developments in the United States. Soc Sci Med 2001; 53 (1): 21–7PubMedCrossRef Marcotte DE, Wilcox-Gok V. Estimating the employment and earnings costs of mental illness: recent developments in the United States. Soc Sci Med 2001; 53 (1): 21–7PubMedCrossRef
23.
Zurück zum Zitat Mincer J, Polachek S. Family Investments in human capital: earnings of women. In: Schultz T, editor. Economics of the family: marriage, children, and human capital. Chicago (IL): National Bureau of Economic Research, The University of Chicago Press, 1974 Mincer J, Polachek S. Family Investments in human capital: earnings of women. In: Schultz T, editor. Economics of the family: marriage, children, and human capital. Chicago (IL): National Bureau of Economic Research, The University of Chicago Press, 1974
24.
Zurück zum Zitat Becker GS. Human capital. Vol. 2. New York (NY): National Bureau of Economic Research, 1975 Becker GS. Human capital. Vol. 2. New York (NY): National Bureau of Economic Research, 1975
25.
Zurück zum Zitat Becker GS. A theory on the allocation of time. Econ J 1965; 75 (299): 493–517CrossRef Becker GS. A theory on the allocation of time. Econ J 1965; 75 (299): 493–517CrossRef
26.
Zurück zum Zitat Borghouts JA, Koes BW, Vondeling H, et al. Cost-of-illness of neck pain in The Netherlands in 1996. Pain 1999; 80 (3): 629–36PubMedCrossRef Borghouts JA, Koes BW, Vondeling H, et al. Cost-of-illness of neck pain in The Netherlands in 1996. Pain 1999; 80 (3): 629–36PubMedCrossRef
27.
Zurück zum Zitat de Lissovoy G, Lazarus SS. The economic cost of migraine: present state of knowledge. Neurology 1994; 44 (6 Suppl. 4): S56–62PubMed de Lissovoy G, Lazarus SS. The economic cost of migraine: present state of knowledge. Neurology 1994; 44 (6 Suppl. 4): S56–62PubMed
28.
Zurück zum Zitat Evers SM, Engel GL, Ament AJ. Cost of stroke in The Netherlands from a societal perspective. Stroke 1997; 28 (7): 1375–81PubMedCrossRef Evers SM, Engel GL, Ament AJ. Cost of stroke in The Netherlands from a societal perspective. Stroke 1997; 28 (7): 1375–81PubMedCrossRef
29.
Zurück zum Zitat Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ 1995; 14: 171–89PubMedCrossRef Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ 1995; 14: 171–89PubMedCrossRef
30.
Zurück zum Zitat Stone PW, Chapman RH, Sandberg EA, et al. Measuring costs in cost-utility analyses: variations in the literature. Int J Technol Assess Health Care 2000; 16 (1): 111–24CrossRef Stone PW, Chapman RH, Sandberg EA, et al. Measuring costs in cost-utility analyses: variations in the literature. Int J Technol Assess Health Care 2000; 16 (1): 111–24CrossRef
31.
Zurück zum Zitat Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ 1997; 6 (3): 253–9PubMedCrossRef Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ 1997; 6 (3): 253–9PubMedCrossRef
32.
Zurück zum Zitat Leigh JP, Romano PS, Schenker MB, et al. Costs of occupational COPD and asthma. Chest 2002; 121 (1): 264–72PubMedCrossRef Leigh JP, Romano PS, Schenker MB, et al. Costs of occupational COPD and asthma. Chest 2002; 121 (1): 264–72PubMedCrossRef
33.
Zurück zum Zitat Ungar WJ, Coyle PC. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 2000; 9 (1): 37–46 Ungar WJ, Coyle PC. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 2000; 9 (1): 37–46
34.
Zurück zum Zitat Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ 1997; 16: 249–55PubMedCrossRef Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ 1997; 16: 249–55PubMedCrossRef
35.
Zurück zum Zitat Hutubessy RC, van Tulder MW, Vondeling H, et al. Indirect costs of back pain in The Netherlands: a comparison of the human capital method with the friction cost method. Pain 1999; 80 (1-2): 201–7PubMedCrossRef Hutubessy RC, van Tulder MW, Vondeling H, et al. Indirect costs of back pain in The Netherlands: a comparison of the human capital method with the friction cost method. Pain 1999; 80 (1-2): 201–7PubMedCrossRef
36.
Zurück zum Zitat Peeples PJ, Wertheimer AI, Mackowiak JI, et al. Controversies in measuring and valuing indirect costs of productivity foregone in a cost of illness evaluation. J Res Pharm Econ 1997; 8: 23–32 Peeples PJ, Wertheimer AI, Mackowiak JI, et al. Controversies in measuring and valuing indirect costs of productivity foregone in a cost of illness evaluation. J Res Pharm Econ 1997; 8: 23–32
37.
Zurück zum Zitat Posnett J, Jan S. Indirect cost in economic evaluation: the opportunity cost of unpaid input. Health Econ 1996; 5: 13–23PubMedCrossRef Posnett J, Jan S. Indirect cost in economic evaluation: the opportunity cost of unpaid input. Health Econ 1996; 5: 13–23PubMedCrossRef
38.
Zurück zum Zitat Pritchard C, Sculpher M. Productivity costs: principles and practice in economic evaluation. London: The Office of Health Economics, 2000 Nov Pritchard C, Sculpher M. Productivity costs: principles and practice in economic evaluation. London: The Office of Health Economics, 2000 Nov
39.
Zurück zum Zitat Weinstein MC, Seigel JE, Garber AM, et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ 1997; 6: 505–10PubMedCrossRef Weinstein MC, Seigel JE, Garber AM, et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ 1997; 6: 505–10PubMedCrossRef
40.
Zurück zum Zitat Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. Reply to Johanesson’s and Karlsson’s comment [reply]. J Health Econ 1997; 16: 257–9CrossRef Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. Reply to Johanesson’s and Karlsson’s comment [reply]. J Health Econ 1997; 16: 257–9CrossRef
41.
Zurück zum Zitat Meltzer D, Johannesson M. Inconsistencies in the “societal perspective” on costs of the panel on cost-effectiveness in health and medicine. Med Decis Making 1999; 19 (4): 371–7PubMedCrossRef Meltzer D, Johannesson M. Inconsistencies in the “societal perspective” on costs of the panel on cost-effectiveness in health and medicine. Med Decis Making 1999; 19 (4): 371–7PubMedCrossRef
42.
Zurück zum Zitat Severens JL, Laheij RJ, Jansen JB, et al. Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther 1998 Sep; 12 (9): 919–23PubMedCrossRef Severens JL, Laheij RJ, Jansen JB, et al. Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther 1998 Sep; 12 (9): 919–23PubMedCrossRef
43.
Zurück zum Zitat Brouwer WBF, van Excel NJ, Koopmanschap MA, et al. The valuation of informal care in economic appraisal. a consideration of individual choice and societal costs of time. Int J Technol Assess Health Care 1999; 15 (1): 147–60PubMedCrossRef Brouwer WBF, van Excel NJ, Koopmanschap MA, et al. The valuation of informal care in economic appraisal. a consideration of individual choice and societal costs of time. Int J Technol Assess Health Care 1999; 15 (1): 147–60PubMedCrossRef
Metadaten
Titel
Valuing patient and caregiver time
A review of the literature
verfasst von
Dr Jennifer E. Tranmer
Denise N. Guerriere
Wendy J. Ungar
Peter C. Coyte
Publikationsdatum
01.05.2005
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 5/2005
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200523050-00005

Weitere Artikel der Ausgabe 5/2005

PharmacoEconomics 5/2005 Zur Ausgabe